Headillu

New treatment of venous thromboembolism

Background information for medical media outside the US only

Disclaimer

The content of the website has been cleared by Boehringer Ingelheim GmbH in compliance with the legal provisions applicable for German companies. Such provisions vary from country to country and can have an impact on the information we can provide to you.

Thus, please contact us directly in case further information is requested which takes into account the framework in your home country.

contact

5 March 2008

International Journalist Summit on Venous Thromboembolism

International Journalist Summit on Venous Thromboembolism
Media event:

"Leading international experts discuss the urgent medical need for improved management of thrombosis by anticoagulatiion treatments after orthopaedic surgery."


University Hospital Mainz: "Introduction to knee replacement surgery"

Boehringer Ingelheim Corporate headquarters: "Thromboembolic Disease: A Global Priority"



Venue:

University Hospital Mainz (10:00 - 12:00 hrs, CET), Mainz, Germany

Boehringer Ingelheim Corporate Headquarters (14:00 - 15:30 hrs, CET), Ingelheim, Germany

International Journalist Summit on Venous Thromboembolism

Medical journalists have the possibility of attending a knee replacement surgery at the Universitätsklinikum Mainz and to discuss with international leading experts about venous thromboembolism and its risks for patients after knee or hip replacements. They will also learn about latest changes in thromboembolic treatment.

Media contact

  • Boehringer Ingelheim GmbH

    Corporate Division Public Relations
    Judith von Gordon
    Binger Strasse 173
    55216 Ingelheim am Rhein
    GERMANY

    • Phone +49/6132/77 35 82
    • Fax +49/6132/77 66 01
    • contact
    • vCard

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed